维普中文期刊产品整合服务
18篇 您的检索式:作者名="Stalmeier"
    题名 作者 年代 出处 被引量
1Efficacy and safetyof palliative chemotherapy for patients with advanced breast cancer pretreated with anthrac-yclines and taxanes:a systematic review显示文摘Oostendorp LJ Stalmeier PF Donders AR 0,,11:1
2Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes:a systematic review显示文摘Oostendorp LJ Stalmeier PF Donders AR 2011Lancet Oncol2011,12,11:1
3Effcacy and safety of palliative chemotherapy Jor patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review 显示文摘Oostendorp LJ Stalmeier PF Donders AR 2011Lancet Oncol2011,12,11:1
4Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pre- treated with anthracyclines and taxanes:a systematic review 显示文摘Oostendorp LJ Stalmeier PF Danders AR 2011Lan- cet Onco12011,12,11:1
5Measuring the quality of life in economic evaluations: The Dutch EQ-5D tariff显示文摘Lamers LM Stalmeier PF 2005Ned Tijdschr Geneeskd2005,1499,5:1
6Visual search and segregation as a function of display complexity显示文摘Scharroo J Stalmeier PFM Boselie E 1994Journal of General Psychology1994,121,1:1
7Systematic review of benefits and risks of second - line irinotecan monotherapy for advanced colorectal cancer 显示文摘Oostendorp L J Stalmeier P F Pasker - de Jong P C 2010Anticancer Drugs2010,21,8:1
8Doctors' and patients' preferences for participation and treatment in curative prostate cancer radiotherapy 显示文摘Stalmeier PF Van Tol-Geerdink JJ Van Lin En 2007J Clin Oncol2007,25,21:1
9Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review显示文摘Oostendorp I3 Stalmeier PF Donders AR 2011Lancet Oncol2011,12,11:1
10Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pretreated with anthracyclines and taxanes: a systematic review显示文摘Oostendorp LJ Stalmeier PF 2011Lancet Oncol2011,12,11:1
11The relationship between change in subjective outcome and change in disease:a potential paradox显示文摘Kievit W Hendrikx J Stalmeier PF 0,,07:1
12TheDutch tariff:results and arguments for an effective design for na-tional EQ-5D valuation studies显示文摘LAMERS LM MCDONNELL J STALMEIER PFM 2006Health Econ2006,5,10:1
13Systematic review of benefits and risks of second - line irinotecan monotherapy for advanced colorectal cancer显示文摘Oostendorp LJ Stalmeier PF Pasker - de Jong PC 2010Anticancer Drugs2010,21,8:1
14Treatment of venous thromboembolism with vitamin K antagonists:patient′s health state valuations and treatment preferences显示文摘Locadia M Bossuyt PM Stalmeier PF 0,,06:1
15Measuring the quality of life in economic evaluations:the Dutch EQ-5D tariff显示文摘Lamers LM Stalmeier PF McDonnell J 0,,28:1
16Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer显示文摘OOSTENDORP L J STALMEIER P F PASKER-DE J P C 2010Anticancer Drugs2010,21,8:1
17The relationship between change in subjective outcome and change in disease: a potential paradox 显示文摘Kievit W Hendrikx J Stalmeier PF 2010Quality of Life Research2010,,:1
18A review on family history of breast cancer: screening and counseling proposals for women with familial ( non - hereditary) breast cancer 显示文摘 Stalmeier PF Peer PG 1997Patient Educ Couns1997,32,12:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费